Overview
Comparison of the Effects Suprascapular Nerve Block and Intra-articular Shoulder Injection
Status:
Completed
Completed
Trial end date:
2023-05-24
2023-05-24
Target enrollment:
0
0
Participant gender:
All
All
Summary
Objectives: In this study, we aimed to compare the efficacy of ultrasonography-guided suprascapular nerve block and intra-articular shoulder injection treatment in terms of joint range of motion, pain and functional status in patients with adhesive capsulitis (AC). Patients and Methods: 60 patients AC were included in our study. The patients were randomized into two groups according to the sealed envelope method. In the evaluation of the patients before the injection, age, gender, body mass index (BMI), occupation, education, duration of complaint, symptomatic side and dominant hand information were recorded. In the first group, 2 ml of 40 mg triamcinolone acetonide and 4 ml of 1% lidocaine injection were mixed with the posterior approach method into the shoulder joint under the guidance of ultrasonography (USG). The second group underwent suprascapular nerve block (SSNB) injection with 2 ml of 40 mg triamcinolone acetonide and 4 ml of 1% lidocaine under USG guidance. Shoulder range of motion (ROM), visual analog scale (VAS) scores and Shoulder Pain and Disability Index (SPADI) scores were compared before the injection, on the tenth day after the injection and at the third month after the injection. Conclusion: As a result of our study, although it was observed that both methods provided improvement in the treatment process, the significant improvement in the SSNB group indicates that it is a more reliable treatment method in AC treatment.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Hitit UniversityTreatments:
Lidocaine
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Criteria
Inclusion Criteria:unilateral stage 2-3 AC
- no shoulder trauma in the last 3 months
- no shoulder injections
- no bleeding disorder
- no history of malignancy
- no history of inflammatory disease
Exlusion Criteria:
- malignancy
- inflammatory disease